OptiVize Device for Dry Eye and MGD

Dry eye disease, often driven by Meibomian Gland Dysfunction (MGD), has long been a challenging condition to treat. Traditional methods frequently focus on alleviating symptoms rather than addressing the root causes. OptiVize, a revolutionary in-office procedure, changes this paradigm by targeting the persistent bacterial biofilm and gland obstructions that perpetuate dry eye disease. By combining advanced vaporization technology with vibratory heated expression techniques, OptiVize offers an effective solution for restoring healthy meibomian gland function and providing lasting relief. A treatment that is often combined with BlephEx to exfoliate, debride, and remove surface biofilm.

Vaporization Technology: Breaking Down Biofilm Barriers

Biofilm is a complex matrix of bacteria and extracellular substances that accumulates on the eyelid margin as well as within the eyelid structures, specifically the meibomian glands. This biofilm obstructs the glands, alters oil production, and contributes to inflammation.

OptiVize employs cutting-edge vaporization technology to directly target this biofilm. Utilizing a precise harmonic waveform delivered via painless electric current, OptiVize penetrates deep into the eyelid tissues to disrupt the biofilm at its molecular level; it vaporizes intraglandular biofilm within the meibomian glands.

This process converts the biofilm into millions of microscopic protein-polysaccharide particles, effectively clearing obstructions without damaging surrounding tissue. This targeted approach ensures comprehensive removal of biofilm from areas previously inaccessible to conventional treatments.

The vaporization phase not only eliminates existing biofilm but also disrupts the protected environment that allows bacteria to thrive. By addressing this root cause, OptiVize creates conditions for long-term improvement in gland function and tear film stability.

Vibratory Thermal Expression: Clearing Obstructions Effectively

Once the biofilm is vaporized, OptiVize employs heated vibratory expression forceps to remove thickened meibomian secretions—often referred to as "sludge"—from the glands. Over time, bacterial enzymes act on meibomian oil, converting it into a viscous paste that obstructs gland ducts. Vibratory thermal expression combines heat and vibration to soften these secretions and facilitate their removal.

The heat component lowers the viscosity of the obstructive material, while vibration creates micro-pressure fluctuations that dislodge and mobilize gland contents. This dual-action approach ensures thorough clearance of both altered oils and accumulated bacterial toxins. 

By restoring normal oil flow dynamics within the meibomian glands, vibratory thermal expression helps stabilize the tear film and reduce evaporation—the primary driver of dry eye symptoms. Patients often experience immediate relief after treatment, with progressive improvement over subsequent sessions.

The Benefits of OptiVize for Dry Eye Patients

OptiVize stands out as a transformative solution for patients struggling with chronic dry eye disease. Its unique combination of vaporization and vibratory thermal expression directly targets the root causes of MGD rather than merely managing symptoms. Key benefits include:

**Comprehensive Biofilm Elimination: Vaporization technology disrupts biofilm deep within eyelid structures, addressing persistent bacterial colonies that other treatments fail to reach.

**Effective Gland Clearance: Heated vibratory expression removes obstructive sludge and toxins, restoring healthy oil flow.

**Long-Term Relief: By resolving underlying dysfunctions, OptiVize provides lasting improvements in tear film stability and ocular comfort.

**Patient-Friendly & Synergistic Procedure: The treatment is gentle, quick, minimally invasive, and requires no downtime. It may also be combined with other procedures such as OptiLight IPL, Meibomian Gland Probing, Rinsada, OptiLift, OptiPlus, Lacrifill, and more.

Clinical Application: The REVVE Protocol

OptiVize is central to the REVVE Treatment Protocol (Regular Exfoliation, Vaporization, Vibratory Expression), which systematically addresses dry eye disease through monthly treatments. The protocol begins with BlephEx micro-blepharoexfoliation to prepare the eyelid surface by removing surface-level biofilm. This step enhances the efficacy of subsequent vaporization and heated expression phases.

The monthly repetition of these steps ensures complete elimination of gland obstructions and restoration of normal oil production. Once clear oil is expressed consistently, maintenance treatments every 3-6 months helps prevent biofilm recurrence. This structured approach provides predictable results.

Study: 156 patients treated, all 312 eyes received the REVVE protocol.

Duration of study was 10-months. Results: Tear Breakup Time (TBUT) increased by an average of 6 seconds per eye, SPEED dry eye questionnaire improved from 17 to 6 (scale 0-28), and no complications or adverse reactions reported.

Conclusion: A Paradigm Shift in Dry Eye Management

OptiVize represents a breakthrough in dry eye treatment by addressing the root causes of MGD—biofilm accumulation and gland obstruction—rather than merely alleviating symptoms. Its innovative vaporization technology combined with vibratory heated expression offers patients lasting relief through restored meibomian gland function.

For individuals who have struggled with chronic dry eye despite trying various therapies, OptiVize provides renewed hope for resolution rather than ongoing discomfort. 

Contact our office today to schedule a consult and/or treatment.

______

Two images below of different patients who had dramatic breakthrough of their ocular surface disease conditions with the REVVE Protocol.